The Influence of the Pretreatment Host Immune State on Response to Radiation Therapy in High Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521 (Updated)
Publication
, Conference
Hall, WA; Karrison, TG; Rosenthal, SA; Amin, M; Gomella, LG; Purdy, JA; Sartor, O; Michalski, JM; Garzotto, M; Bergom, C; Jani, A; Lawton, CAF ...
Published in: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2020
Duke Scholars
Published In
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
EISSN
1879-355X
ISSN
0360-3016
Publication Date
2020
Volume
108
Issue
3
Start / End Page
E562 / E563
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hall, W. A., Karrison, T. G., Rosenthal, S. A., Amin, M., Gomella, L. G., Purdy, J. A., … Feng, F. Y. (2020). The Influence of the Pretreatment Host Immune State on Response to Radiation Therapy in High Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521 (Updated). In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (Vol. 108, pp. E562–E563).
Hall, W. A., T. G. Karrison, S. A. Rosenthal, M. Amin, L. G. Gomella, J. A. Purdy, O. Sartor, et al. “The Influence of the Pretreatment Host Immune State on Response to Radiation Therapy in High Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521 (Updated).” In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108:E562–63, 2020.
Hall WA, Karrison TG, Rosenthal SA, Amin M, Gomella LG, Purdy JA, et al. The Influence of the Pretreatment Host Immune State on Response to Radiation Therapy in High Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521 (Updated). In: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2020. p. E562–3.
Hall, W. A., et al. “The Influence of the Pretreatment Host Immune State on Response to Radiation Therapy in High Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521 (Updated).” INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 108, no. 3, 2020, pp. E562–63.
Hall WA, Karrison TG, Rosenthal SA, Amin M, Gomella LG, Purdy JA, Sartor O, Michalski JM, Garzotto M, Bergom C, Jani A, Lawton CAF, Simko J, Moore J, Gore EM, Lee WR, Nguyen PL, Danielson BL, Sandler HM, Feng FY. The Influence of the Pretreatment Host Immune State on Response to Radiation Therapy in High Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521 (Updated). INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2020. p. E562–E563.
Published In
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
EISSN
1879-355X
ISSN
0360-3016
Publication Date
2020
Volume
108
Issue
3
Start / End Page
E562 / E563
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences